BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38413252)

  • 1. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
    Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
    Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity.
    Kiyozawa D; Kohashi K; Takamatsu D; Yamamoto T; Eto M; Iwasaki T; Motoshita J; Shimokama T; Kinjo M; Oshiro Y; Yonemasu H; Oda Y
    Hum Pathol; 2021 Jun; 112():48-58. PubMed ID: 33811832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary renal neoplasm with reverse polarity with a favorable prognosis should be separated from papillary renal cell carcinoma.
    Liu Y; Zhang H; Li X; Wang S; Zhang Y; Zhang X; Xu T; Dong Y; Dong L; Zhou L; Yang X; Wang C
    Hum Pathol; 2022 Sep; 127():78-85. PubMed ID: 35724772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
    Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
    Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
    Kim B; Lee S; Moon KC
    Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary renal neoplasm with reverse polarity is biologically and clinically distinct from eosinophilic papillary renal cell carcinoma.
    Castillo VF; Trpkov K; Van der Kwast T; Rotondo F; Hamdani M; Saleeb R
    Pathol Int; 2024 Apr; 74(4):222-226. PubMed ID: 38456605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary renal neoplasm with reverse polarity-a comparative study with CCPRCC, OPRCC, and PRCC1.
    Wang T; Ding X; Huang X; Ye J; Li H; Cao S; Gao Y; Ma X; Huang Q; Wang B
    Hum Pathol; 2022 Nov; 129():60-70. PubMed ID: 35977593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillary renal neoplasm with reverse polarity: an observational study of histology, immunophenotypes, and molecular variation.
    Han H; Yin SY; Song RX; Zhao J; Yu YW; He MX; Wang H
    Transl Androl Urol; 2024 Mar; 13(3):383-396. PubMed ID: 38590969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Munari E; Marchionni L; Chitre A; Hayashi M; Martignoni G; Brunelli M; Gobbo S; Argani P; Allaf M; Hoque MO; Netto GJ
    Hum Pathol; 2014 Jun; 45(6):1130-8. PubMed ID: 24703100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei.
    Tong K; Zhu W; Fu H; Cao F; Wang S; Zhou W; Liu C; Chen D; Fan S; Hu Z
    Histopathology; 2020 Jun; 76(7):1070-1083. PubMed ID: 31997427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
    Wei S; Krause HB; Geynisman DM; Elliott A; Kutikov A; Uzzo RG; Pei J; Barata P; Carneiro B; Heath E; Ryan C; Farrell A; Nabhan C; Ali-Fehmi R; Naqash AR; Argani P; McKay RR
    Mod Pathol; 2024 Feb; 37(2):100404. PubMed ID: 38104891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
    Paulucci DJ; Sfakianos JP; Skanderup AJ; Kan K; Tsao CK; Galsky MD; Hakimi AA; Badani KK
    Oncotarget; 2017 Jan; 8(3):5196-5205. PubMed ID: 28029648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary renal cell neoplasm with reverse polarity: A new subtype of renal tumour with favorable prognosis.
    Conde-Ferreirós M; Domínguez-de Dios J; Juaneda-Magdalena L; Bellas-Pereira A; San Miguel Fraile MP; Peteiro Cancelo MÁ; Gómez-de María C; Álvarez Sarria M; Betancor Santos MÁ; González-Carreró J; Ortiz-Rey JA
    Actas Urol Esp (Engl Ed); 2022 Dec; 46(10):600-605. PubMed ID: 36216763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Papillary renal neoplasm with reverse polarity: a clinicopathological analysis].
    Ji RH; Wang XT; Li R; Ye SB; Wang X; Ma HH; Lu ZF; Rao Q; Xia QY
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):23-27. PubMed ID: 34979749
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.
    Lawrie CH; Larrea E; Larrinaga G; Goicoechea I; Arestin M; Fernandez-Mercado M; Hes O; Cáceres F; Manterola L; López JI
    J Pathol; 2014 Jan; 232(1):32-42. PubMed ID: 24155122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary renal neoplasm with reverse polarity: A clinicopathological and molecular genetic characterization of 16 cases with expanding the morphologic spectrum and further support for a novel entity.
    Shen M; Yin X; Bai Y; Zhang H; Ru G; He X; Teng X; Chen G; Zhao M
    Front Oncol; 2022; 12():930296. PubMed ID: 35936734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms.
    Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI
    J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomorphology of papillary renal neoplasm with reverse polarity.
    Satturwar S; Parwani AV
    Cytojournal; 2023; 20():43. PubMed ID: 38053633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary renal neoplasm with reverse polarity with a favorable prognosis: Two cases report and literature review.
    Yuzhi Z; Zhen L; Yu X; Boju P; Weigang Y; Xingcheng W
    Front Oncol; 2022; 12():1011422. PubMed ID: 36387104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.